Joint Formulary & PAD

Atropine sulfate - Bradycardia

You are here : Home > Formulary Search > Atropine sulfate - Bradycardia

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Intravenous injection (IV)
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Atropine sulfate
Indication :
Bradycardia
Group Name :
Keywords :
Brand Names Include :
Important Information :

https://www.toxbase.org/

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (1)

05 Feb 25 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

Other Indications

Below are listed other indications that Atropine sulfate is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Bradycardia.

  • No records returned.